Centene Research and Development Expenses 2010-2023 | CNC

Centene annual/quarterly research and development expenses history and growth rate from 2010 to 2023. Research and development expenses can be defined as an expense arising from studies and product development processes.
  • Centene research and development expenses for the quarter ending December 31, 2023 were $M, a NAN% increase year-over-year.
  • Centene research and development expenses for the twelve months ending December 31, 2023 were $0M, a NAN% increase year-over-year.
  • Centene annual research and development expenses for 2023 were $0B, a NAN% decline from 2022.
  • Centene annual research and development expenses for 2022 were $0B, a NAN% decline from 2021.
  • Centene annual research and development expenses for 2021 were $0B, a NAN% decline from 2020.
Centene Annual Research and Development Expenses
(Millions of US $)
2023 $
2022 $
2021 $
2020 $
2019 $
2018 $
2017 $
2016 $
2015 $
2014 $
2013 $
2012 $
2011 $
2010 $
2009 $
Centene Quarterly Research and Development Expenses
(Millions of US $)
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31
2019-12-31
2019-09-30
2019-06-30
2019-03-31
2018-12-31
2018-09-30
2018-06-30
2018-03-31
2017-12-31
2017-09-30
2017-06-30
2017-03-31
2016-12-31
2016-09-30
2016-06-30
2016-03-31
2015-12-31
2015-09-30
2015-06-30
2015-03-31
2014-12-31
2014-09-30
2014-06-30
2014-03-31
2013-12-31
2013-09-30
2013-06-30
2013-03-31
2012-12-31
2012-09-30
2012-06-30
2012-03-31
2011-12-31
2011-09-30
2011-06-30
2011-03-31
2010-12-31
2010-09-30
2010-06-30
2010-03-31
2009-12-31
2009-09-30
2009-06-30
2009-03-31
Sector Industry Market Cap Revenue
Medical Medical - Health Maintenance Organizations $40.478B $153.999B
Centene Corporation is a well-diversified, multi-national healthcare company that primarily provides a set of services to government sponsored healthcare programs. The company serves the under-insured and uninsured individuals through member-focused services. It is also engaged in providing education and outreach programs to inform and assist members in accessing quality, appropriate healthcare services. Through a diversified product portfolio and expanding geographic reach, Centene continues to deliver results by growing premium and service revenues profitably. The company operates in two segments: Managed Care and Specialty Services. Managed Care - This segment provides health plan coverage to individuals through Government subsidized programs, including Medicaid. Specialty Services - This segment consists of its specialty companies offering diversified healthcare services and products to state programs, correctional facilities, healthcare organizations, employer groups and other commercial organizations.
Stock Name Country Market Cap PE Ratio
UnitedHealth Group (UNH) United States $462.993B 19.53
Cigna Group (CI) United States $98.673B 13.28
Humana (HUM) United States $39.059B 13.60
Molina Healthcare (MOH) United States $20.182B 16.55
Select Medical Holdings (SEM) United States $4.270B 14.93
Joint (JYNT) United States $0.239B 227.57
Aethlon Medical (AEMD) United States $0.003B 0.00